These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs. Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426 [TBL] [Abstract][Full Text] [Related]
9. Effects of dichloroacetate in the treatment of hypoxic lactic acidosis in dogs. Graf H; Leach W; Arieff AI J Clin Invest; 1985 Sep; 76(3):919-23. PubMed ID: 4044835 [TBL] [Abstract][Full Text] [Related]
10. Dichloroacetate, sodium: 3-month oral toxicity studies in rats and dogs. Katz R; Tai CN; Diener RM; McConnell RF; Semonick DE Toxicol Appl Pharmacol; 1981 Feb; 57(2):273-87. PubMed ID: 7222043 [No Abstract] [Full Text] [Related]
11. Effects of sodium dichloroacetate in awake, healthy, Yucatan miniature swine. Weingand KW; Fettman MJ; Phillips RW; Hand MS Am J Vet Res; 1986 Feb; 47(2):441-6. PubMed ID: 3513679 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs. Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512 [TBL] [Abstract][Full Text] [Related]
14. [Comparative effects of dichloroacetate and sodium bicarbonate on plasma lactic acid levels in experimentally produced hypoxia]. Nakata F; Kemmotsu O; Tanaka R Masui; 1987 Jul; 36(7):1100-7. PubMed ID: 2824875 [No Abstract] [Full Text] [Related]
15. Concentrations of phenethylamine in dog following single doses and during intravenous self-administration. Cone EJ; Risner ME; Neidert GL Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):211-32. PubMed ID: 734213 [TBL] [Abstract][Full Text] [Related]
16. Plasma nicotine pharmacokinetics in dogs after intravenous administration: determination by radioimmunoassay. Monji N; Castro A Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):267-77. PubMed ID: 461952 [TBL] [Abstract][Full Text] [Related]
17. Disposition and pharmacodynamics of dichloroacetate (DCA) and oxalate following oral DCA doses. Curry SH; Lorenz A; Chu PI; Limacher M; Stacpoole PW Biopharm Drug Dispos; 1991 Jul; 12(5):375-90. PubMed ID: 1878534 [TBL] [Abstract][Full Text] [Related]
18. A rapid microassay for dichloroacetate in serum by gel-permeation chromatography. Sakakihara Y; Nakamura G; Tokoeda Y; Abe T; Kamoshita S Eur J Clin Chem Clin Biochem; 1994 Feb; 32(2):79-83. PubMed ID: 8003581 [TBL] [Abstract][Full Text] [Related]
19. Effect of dichloroacetate in the treatment of anoxic lactic acidosis in dogs. Sheikh A; Fleisher G; Delgado Paredes C; Caputo G; Schaible D; Egler J; Swedlow D Crit Care Med; 1986 Nov; 14(11):970-3. PubMed ID: 3021391 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs. Grubb MF; Wong YN; Burcham DL; Saxton PL; Quon CY; Huang SM Drug Metab Dispos; 1994; 22(5):709-12. PubMed ID: 7835221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]